RUNX2 and osteoporosis: CCDC91 is a known target of Runx2 [17], and variants affecting its expression have been implicated in musculoskeletal traits such as height, estimated bone mineral density, spine bone area, neck bone area, OPLL [18], osteoporosis [19], and osteoarthritis [20].